Michael H. Davidson

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Emeryville, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Michael Marino as Attorney-in-Fact for Michael H. Davidson
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Michael H. Davidson

Form 4 holding Director

TENAX THERAPEUTICS, INC.

Security class
Pre-Funded Warrant
Shares / value
47,500
Estimated value
$427,500
Report date
09 Jan 2026
Price
$9.00
Ownership
Direct
Underlying class
Common Stock
Underlying amount
47,500
Form 4 holding Director

TENAX THERAPEUTICS, INC.

Security class
Stock Option (right to buy)
Shares / value
30,000
Estimated value
$270,000
Report date
09 Jan 2026
Price
$9.00
Ownership
Direct
Underlying class
Common Stock
Underlying amount
30,000
Form 4 holding Director

Silence Therapeutics plc

Security class
Share Option (Right to Buy)
Shares / value
48,000
Estimated value
Report date
02 Jan 2025
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
Form 4 holding Director

BioAge Labs, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
22,000
Estimated value
Report date
10 Jun 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Executive Officer, Director

NewAmsterdam Pharma Co N.V.

Security class
Restricted Stock Unit
Shares / value
0
Estimated value
Report date
26 Mar 2025
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount

Insider Reports Filed by Michael H. Davidson

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .